140 related articles for article (PubMed ID: 33576213)
1. 2-Methoxy-1,4-Naphthoquinone (MNQ) Inhibits Glucose Uptake and Lactate Production in Triple-Negative Breast Cancer Cells.
Daud SM; Yaacob NS; Fauzi AN
Asian Pac J Cancer Prev; 2021 Feb; 22(S1):59-65. PubMed ID: 33576213
[TBL] [Abstract][Full Text] [Related]
2. 2-Methoxy-1,4-Naphthoquinone (MNQ) suppresses the invasion and migration of a human metastatic breast cancer cell line (MDA-MB-231).
Liew K; Yong PV; Lim YM; Navaratnam V; Ho AS
Toxicol In Vitro; 2014 Apr; 28(3):335-9. PubMed ID: 24291160
[TBL] [Abstract][Full Text] [Related]
3. Differential proteomic analysis on the effects of 2-methoxy-1,4-naphthoquinone towards MDA-MB-231 cell line.
Liew K; Yong PV; Navaratnam V; Lim YM; Ho AS
Phytomedicine; 2015 May; 22(5):517-27. PubMed ID: 25981917
[TBL] [Abstract][Full Text] [Related]
4. Antiglycolytic Activities of
Muhammad SNH; Yaacob NS; Safuwan NAM; Fauzi AN
Anticancer Agents Med Chem; 2022; 22(7):1363-1369. PubMed ID: 33906591
[TBL] [Abstract][Full Text] [Related]
5. Effect of metformin on estrogen and progesterone receptor-positive (MCF-7) and triple-negative (MDA-MB-231) breast cancer cells.
Amaral I; Silva C; Correia-Branco A; Martel F
Biomed Pharmacother; 2018 Jun; 102():94-101. PubMed ID: 29550639
[TBL] [Abstract][Full Text] [Related]
6. Comparative transcriptome analysis to identify candidate genes involved in 2-methoxy-1,4-naphthoquinone (MNQ) biosynthesis in Impatiens balsamina L.
Foong LC; Chai JY; Ho ASH; Yeo BPH; Lim YM; Tam SM
Sci Rep; 2020 Sep; 10(1):16123. PubMed ID: 32999341
[TBL] [Abstract][Full Text] [Related]
7. Triple Isozyme Lactic Acid Dehydrogenase Inhibition in Fully Viable MDA-MB-231 Cells Induces Cytostatic Effects That Are Not Reversed by Exogenous Lactic Acid.
Mazzio E; Mack N; Badisa RB; Soliman KFA
Biomolecules; 2021 Nov; 11(12):. PubMed ID: 34944395
[TBL] [Abstract][Full Text] [Related]
8. Stable shRNA Silencing of Lactate Dehydrogenase A (LDHA) in Human MDA-MB-231 Breast Cancer Cells Fails to Alter Lactic Acid Production, Glycolytic Activity, ATP or Survival.
Mack N; Mazzio EA; Bauer D; Flores-Rozas H; Soliman KF
Anticancer Res; 2017 Mar; 37(3):1205-1212. PubMed ID: 28314283
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of aerobic glycolysis enhances the anti-tumor efficacy of Zoptarelin Doxorubicin in triple-negative breast cancer cells.
Gründker C; Wokoun U; Hellriegel M; Emons G
J Obstet Gynaecol Res; 2019 Jul; 45(7):1334-1342. PubMed ID: 31016845
[TBL] [Abstract][Full Text] [Related]
10. 2-Methoxy-1,4-naphthoquinone (MNQ) induces apoptosis of A549 lung adenocarcinoma cells via oxidation-triggered JNK and p38 MAPK signaling pathways.
Ong JY; Yong PV; Lim YM; Ho AS
Life Sci; 2015 Aug; 135():158-64. PubMed ID: 25896662
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial dysfunction in some triple-negative breast cancer cell lines: role of mTOR pathway and therapeutic potential.
Pelicano H; Zhang W; Liu J; Hammoudi N; Dai J; Xu RH; Pusztai L; Huang P
Breast Cancer Res; 2014 Sep; 16(5):434. PubMed ID: 25209360
[TBL] [Abstract][Full Text] [Related]
12. The anti-proliferative effect of metformin in triple-negative MDA-MB-231 breast cancer cells is highly dependent on glucose concentration: implications for cancer therapy and prevention.
Zordoky BN; Bark D; Soltys CL; Sung MM; Dyck JR
Biochim Biophys Acta; 2014 Jun; 1840(6):1943-57. PubMed ID: 24462945
[TBL] [Abstract][Full Text] [Related]
13. MNQ derivative D
Yang X; Qin X; Wang K; Kebreab E; Lyu L
Theriogenology; 2023 Aug; 206():149-160. PubMed ID: 37210939
[TBL] [Abstract][Full Text] [Related]
14.
Liu H; Sun H; Zhang B; Liu S; Deng S; Weng Z; Zuo B; Yang J; He Y
Breast Cancer; 2020 May; 27(3):372-380. PubMed ID: 31781983
[TBL] [Abstract][Full Text] [Related]
15. Let-7a-5p inhibits triple-negative breast tumor growth and metastasis through GLUT12-mediated warburg effect.
Shi Y; Zhang Y; Ran F; Liu J; Lin J; Hao X; Ding L; Ye Q
Cancer Lett; 2020 Dec; 495():53-65. PubMed ID: 32946964
[TBL] [Abstract][Full Text] [Related]
16. Electroporation enhances cell death in 3D scaffold-based MDA-MB-231 cells treated with metformin.
Sahu P; Camarillo IG; Dettin M; Zamuner A; Teresa Conconi M; Barozzi M; Giri P; Sundararajan R; Sieni E
Bioelectrochemistry; 2024 Oct; 159():108734. PubMed ID: 38762949
[TBL] [Abstract][Full Text] [Related]
17. Rhizoma Amorphophalli inhibits TNBC cell proliferation, migration, invasion and metastasis through the PI3K/Akt/mTOR pathway.
Wu C; Qiu S; Liu P; Ge Y; Gao X
J Ethnopharmacol; 2018 Jan; 211():89-100. PubMed ID: 28962890
[TBL] [Abstract][Full Text] [Related]
18. EGFR Signaling Enhances Aerobic Glycolysis in Triple-Negative Breast Cancer Cells to Promote Tumor Growth and Immune Escape.
Lim SO; Li CW; Xia W; Lee HH; Chang SS; Shen J; Hsu JL; Raftery D; Djukovic D; Gu H; Chang WC; Wang HL; Chen ML; Huo L; Chen CH; Wu Y; Sahin A; Hanash SM; Hortobagyi GN; Hung MC
Cancer Res; 2016 Mar; 76(5):1284-96. PubMed ID: 26759242
[TBL] [Abstract][Full Text] [Related]
19. Co-treatment of breast cancer cells with pharmacologic doses of 2-deoxy-D-glucose and metformin: Starving tumors.
Wokoun U; Hellriegel M; Emons G; Gründker C
Oncol Rep; 2017 Apr; 37(4):2418-2424. PubMed ID: 28350075
[TBL] [Abstract][Full Text] [Related]
20. KR-33028, a potent inhibitor of the Na
Amith SR; Wilkinson JM; Fliegel L
Biochem Pharmacol; 2016 Oct; 118():31-39. PubMed ID: 27521504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
